Manuel Guzman-Blanco

TL;DR: This first large epidemiologic study of candidemia in Latin America showed a high incidence ofCandida albicans, high percentage of children, typical species distribution, and low resistance rates.

TL;DR: The AGORA (Antimicrobials: A Global Alliance for Optimizing their Rational Use in Intra-Abdominal Infections) project as discussed by the authors is an international task force from 79 different countries has joined this project by sharing a document on the rational use of antimicrobial therapy for patients with IAIs.

TL;DR: LATAM nations demonstrated variable levels of antimicrobial R especially among Enterobacteriaceae, PSA and ACB, and MRSA (48%), VRE (14%) and multidrug-R SPN were also regional therapeutic challenges.

TL;DR: A variety of epidemic MRSA clones are circulating in Latin America, some of which harbor genes that encode multidrug resistance or enhanced pathogenicity, and implications for clinical practice are reviewed.

TL;DR: Increasing prevalence of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii strains in the nosocomial setting in Latin America represents an emerging challenge to public health, as the range of therapeutic agents active against these pathogens becomes increasingly constrained.